News and Announcements
Cortex Signs MOU with Telstra & HOA, Receives Trademark Registration Approval & Establishes a $23m Sales Pipeline
- Published August 08, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Cortex is an Australian innovation delivering convenient digital information, entertainment and world-leading public amenities in a single point of presence. Australia’s next world-first, Cortex will define our next-gen digital public spaces.
- Cortex Virtual Reality platform established and Brisbane-based showroom setup to facilitate virtual + onsite Cortex Product demonstrations.
- 6 staff hired, doubling our R&D and Engineering teams.
- Trademark registration approved and Cortex has an entirely new Web presence. Social Media Channels (Twitter + LinkedIn) are now launched.
- Second prototype completed and presented at industry tradeshows for industry feedback.
- Agreements: MOU with Telstra and HOA secured with SA Manufacturing partner.
- Articles published in Security Magazine and syndicated across News Corp print and online.
- Established Sales Pipeline worth $23m over 5 years across 7 local Australian councils including Brisbane, Melbourne, Adelaide, Newcastle and Sunshine Coast.
Cortex has been demonstrated to hundreds of industry partners and government decision makers at the Australian Smart Communities Association 2017 Conference (May, Adelaide) and the Australian Security Exhibition (July, Sydney). Scheduled to exhibit with the Brisbane Lord Mayor Delegation to Korea (Asia Pacific Cities Summit in September), and together with Austrade in Washington DC for Smart Cities Week in October.
ABOUT SYLO PTY LTD – CORTEX
Sylo is an Australian organisation working in the global market and specialises in best-of-breed innovation, custom solutions, tier 1 products and value-add services for the Security Industry.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
